Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation
Key Finding
Noopept consistently improved memory, learning, and cognitive function with neuroprotective effects in clinical trials.
Plain-English Summary
This systematic review examined the preclinical and clinical evidence for Noopept, a synthetic nootropic dipeptide structurally related to piracetam. The review covered multiple studies in both animal models and human patients with cognitive impairment.
Studies consistently showed that Noopept improved memory formation and retrieval, enhanced learning, and provided neuroprotective effects. Clinical trials in patients with mild cognitive impairment demonstrated improvements in memory, attention, and overall cognitive function at doses of 10-20mg twice daily.
Noopept appears to work by enhancing NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor) expression, promoting neuroplasticity and neuronal health. It also demonstrates antioxidant and anti-inflammatory properties. Effects are reported to be significantly more potent than piracetam on a per-milligram basis. The compound showed good tolerability with minimal adverse effects in clinical use.